Cargando…
Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5
Proper regulation of Wnt signaling is critical for normal bone development and homeostasis. Mutations in several Wnt signaling components, which increase the activity of the pathway in the skeleton, cause high bone mass in human subjects and mouse models. Increased bone mass is often accompanied by...
Autores principales: | Diegel, Cassandra R., Kramer, Ina, Moes, Charles, Foxa, Gabrielle E., McDonald, Mitchell J., Madaj, Zachary B., Guth, Sabine, Liu, Jun, Harris, Jennifer L., Kneissel, Michaela, Williams, Bart O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447437/ https://www.ncbi.nlm.nih.gov/pubmed/37612291 http://dx.doi.org/10.1038/s41413-023-00278-5 |
Ejemplares similares
-
Parathyroid Hormone (PTH)–Induced Bone Gain Is Blunted in SOST Overexpressing and Deficient Mice
por: Kramer, Ina, et al.
Publicado: (2010) -
Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
por: Madan, Babita, et al.
Publicado: (2018) -
SOST and DKK: Antagonists of LRP Family Signaling as Targets for Treating Bone Disease
por: Mason, James J., et al.
Publicado: (2010) -
Cortical bone adaptation to a moderate level of mechanical loading in male Sost deficient mice
por: Yang, Haisheng, et al.
Publicado: (2020) -
Lrp5 and Lrp6 Exert Overlapping Functions in Osteoblasts during Postnatal Bone Acquisition
por: Riddle, Ryan C., et al.
Publicado: (2013)